Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
Strontium is Incorporated Into Mineral Crystals Only in Newly Formed Bone During Strontium Ranelate Treatment
Journal of Bone and Mineral Research, 11/03/09
Li C et al. – The thickness and length of the plate–shaped bone mineral crystals were not affected by the strontium ranelate treatment. As a consequence, there was no indication for a change in human bone tissue quality at the nanoscale after a 36–month treatment of postmenopausal osteoporotic women with strontium ranelate, except for a partial replacement of calcium by strontium ions in the hydroxyapatite crystals, only in newly formed bone.
Related Articles
Relationship between 3-month changes in biochemical markers of bone remodelling and changes in bone mineral density and fracture incidence in patients treated with strontium ranelate for 3 years
Osteoporosis International, 10/13/09
Relevance Score: 68%
Osteoporosis and venous thromboembolism: a retrospective cohort study in the UK General Practice Research Database
Osteoporosis International, 10/12/09
Relevance Score: 68%
The Effect of Prior Bisphosphonate Therapy on the Subsequent BMD and Bone Turnover Response to Strontium Ranelate
Journal of Bone and Mineral Research, 10/02/09
Relevance Score: 66%
Bone Material Quality in Transiliac Bone Biopsies of Postmenopausal Osteoporotic Women After 3 Years Strontium Ranelate Treatment
Journal of Bone and Mineral Research, 10/28/09
Relevance Score: 64%
Taking Charge of Bone Loss During Menopause
Internet Source, 10/16/09
Relevance Score: 43%
Today in Bone Metabolism...keeping you current
Receive free subspecialty "5-minute updates" via email
The Role of Quantitative Bone Scanning in the Assessment of Bone Turnover in Patients with Charcot Foot
Diabetes Care, 11/25/09
Assessment of Regional Changes in Skeletal Metabolism Following 3 and 18 Months of Teriparatide Treatment
Journal of Bone and Mineral Research, 11/25/09
Relationship Between Genotype and Skeletal Phenotype in Children and Adolescents With Osteogenesis Imperfecta
Journal of Bone and Mineral Research, 11/25/09
Article Search
Sponsor


See Latest Articles


